Nishant P Shah1,2, Ahmed AbuHaniyeh3, Haitham Ahmed4. 1. Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA. shahn2@ccf.org. 2. , 9500 Euclid Avenue J3-6, Cleveland, OH, 44095, USA. shahn2@ccf.org. 3. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA. 4. Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.
Abstract
PURPOSE OF REVIEW: Cardiovascular (CV) disease remains the leading cause of death in the USA despite major advances in its treatment. With time, cardiac rehabilitation (CR) programs have gathered interest to help increase CV health and improve functional status after a CV event. Patients with heart failure have also been shown to benefit. In this review, we will evaluate the current literature showcasing the benefits of CR, particularly in patients with heart failure, discuss current limitations, and avenues for future investigation. RECENT FINDINGS: Studies have shown that CR is beneficial in reducing morbidity, mortality, hospitalizations, activity-related symptoms, and increasing quality of life. Similar findings have also been observed in patients with heart failure who underwent CR in addition to optimal medical management. The positive effects of CR are well established in patients with coronary disease. Recent literature is also showing a trend to benefit in patients with heart failure, though much of the evidence is limited to patients with systolic dysfunction. Despite recommendations by professional societies, the use of CR remains underutilized. Further investigation is needed to better understand the impact of CR in heart failure. Moreover, strategies to increase CR utilization must be explored.
PURPOSE OF REVIEW: Cardiovascular (CV) disease remains the leading cause of death in the USA despite major advances in its treatment. With time, cardiac rehabilitation (CR) programs have gathered interest to help increase CV health and improve functional status after a CV event. Patients with heart failure have also been shown to benefit. In this review, we will evaluate the current literature showcasing the benefits of CR, particularly in patients with heart failure, discuss current limitations, and avenues for future investigation. RECENT FINDINGS: Studies have shown that CR is beneficial in reducing morbidity, mortality, hospitalizations, activity-related symptoms, and increasing quality of life. Similar findings have also been observed in patients with heart failure who underwent CR in addition to optimal medical management. The positive effects of CR are well established in patients with coronary disease. Recent literature is also showing a trend to benefit in patients with heart failure, though much of the evidence is limited to patients with systolic dysfunction. Despite recommendations by professional societies, the use of CR remains underutilized. Further investigation is needed to better understand the impact of CR in heart failure. Moreover, strategies to increase CR utilization must be explored.
Authors: Pratik B Sandesara; Cameron T Lambert; Neil F Gordon; Gerald F Fletcher; Barry A Franklin; Nanette K Wenger; Laurence Sperling Journal: J Am Coll Cardiol Date: 2015-02-03 Impact factor: 24.094
Authors: Sergey Kachur; Vasutakarn Chongthammakun; Carl J Lavie; Alban De Schutter; Ross Arena; Richard V Milani; Barry A Franklin Journal: Prog Cardiovasc Dis Date: 2017-07-06 Impact factor: 8.194
Authors: Ambarish Pandey; Dalane W Kitzman; Peter Brubaker; Mark J Haykowsky; Timothy Morgan; J Thomas Becton; Jarett D Berry Journal: J Am Geriatr Soc Date: 2017-03-24 Impact factor: 5.562
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Steven J Keteyian; Eric S Leifer; Nancy Houston-Miller; William E Kraus; Clinton A Brawner; Christopher M O'Connor; David J Whellan; Lawton S Cooper; Jerome L Fleg; Dalane W Kitzman; Alain Cohen-Solal; James A Blumenthal; David S Rendall; Ileana L Piña Journal: J Am Coll Cardiol Date: 2012-10-10 Impact factor: 24.094
Authors: Jose A Suaya; Donald S Shepard; Sharon-Lise T Normand; Philip A Ades; Jeffrey Prottas; William B Stason Journal: Circulation Date: 2007-09-24 Impact factor: 29.690
Authors: Lindsey Anderson; Neil Oldridge; David R Thompson; Ann-Dorthe Zwisler; Karen Rees; Nicole Martin; Rod S Taylor Journal: J Am Coll Cardiol Date: 2016-01-05 Impact factor: 24.094
Authors: Mark Mills; Elizabeth Johnson; Hamza Zafar; Andrew Horwood; Nicola Lax; Sarah Charlesworth; Anna Gregory; Justin Lee; Jonathan Sahu; Graeme Kirkwood; Nicholas Kelland; Andreas Kyriacou Journal: Br J Cardiol Date: 2020-06-11
Authors: Michael Sola; Andrea D Thompson; Antoinette B Coe; Vincent D Marshall; Michael P Thomas; Hallie C Prescott; Matthew C Konerman Journal: Am J Cardiol Date: 2019-08-07 Impact factor: 2.778
Authors: Francisco José Ferrer-Sargues; Óscar Fabregat-Andrés; Isabel Martínez-Hurtado; Pablo Salvador-Coloma; Francisco José Martínez-Olmos; Marta Lluesma-Vidal; Gemma Biviá-Roig; María José Segrera-Rovira; María Dolores Arguisuelas; Noemí Valtueña-Gimeno Journal: PLoS One Date: 2020-12-23 Impact factor: 3.240